The price of CVS Health Corp (NYSE:CVS) shares last traded on Wall Street rose 1.16% to $56.47.
CVS stock price is now -20.12% away from the 50-day moving average and -21.47% away from the 200-day moving average. The market capitalization of the company currently stands at $70.89B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $99 to $59, TD Cowen Downgraded its rating from Buy to Hold for CVS Health Corp (NYSE: CVS). On May 02, 2024, UBS Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $85 to quote $60, while ‘Leerink Partners’ rates the stock as ‘Market Perform’
In other news, Mahoney Michael F, Director bought 9,181 shares of the company’s stock on May 02 ’24. The stock was bought for $500,294 at an average price of $54.49. Upon completion of the transaction, the Director now directly owns 9,356 shares in the company, valued at $0.53 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 02 ’24, Director LUDWIG EDWARD J bought 1,000 shares of the business’s stock. A total of $53,879 was incurred on buying the stock at an average price of $53.88. This leaves the insider owning 21,630 shares of the company worth $1.22 million. A total of 0.18% of the company’s stock is owned by insiders.
During the past 12 months, CVS Health Corp has had a low of $53.70 and a high of $83.25. As of last week, the company has a debt-to-equity ratio of 1.11, a current ratio of 0.81, and a quick ratio of 0.61.
According to the Healthcare Plans Company, earnings per share came in at 2.21, beating analysts’ expectations of 2.11 by 0.1. This compares to $1.66 EPS in the same period last year. The net profit margin was 2.03% and return on equity was 10.07% for CVS. The company reported revenue of $88.44 billion for the quarter, compared to $85.28 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 3.7 percent. For the current quarter, analysts expect CVS to generate $91.53B in revenue.
